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Background/Introduction
Systolic anterior motion (SAM) and mitral regurgitation
(MR) in patients with hypertrophic obstructive cardiomyo-
pathy (HOCM) is associated with: Venturi effect and
small LV cavity. According 2011 ACCF/AHA guideline
extended myoectomy is gold standard in treatment
patients with HOCM, however mitral subvalvular appara-
tus (MSA) intervention is still unclear.
Aims/Objectives
The purpose of this randomize study was assessment
MSA intervention during extended septal myectomy in
patient with HOCM and moderate to severe MR.
Method
Between 2010 and 2014, 182 patients underwent of
extended myectomy procedures. 70 patient met inclusion
criteria: were randomly assigned to receive MSA interven-
tion in addition to septal myectomy (MSI group; n = 36)
or undergo septal myectomy only (without MSI group;
n = 34). A primary HOCM was the main indication for
surgery according to 2011 ACCF/AHA guidelines. Mean
age was 52.8 ± 14.2 years (range 22 to 74 years). Mean
peak gradient was 90.7 ± 24.2 mm Hg. Mean thickness of
interventricular septum was 26.1 ± 4.3 mm. SAM syn-
drome observed in all patients. MR: moderate - 42 (60%)
pts, severe 28 (40%) pts.
Results
There were no early death. MSA intervention include:
mobilization papillary muscle 36 (100%) pts, secondary
chords resected 36 (100%) pts (from 2 to 6), longitudinal
resection papillary muscles (papillary muscles more than
15 mm) 32 (88.9%) pts and excision of abnormal papil-
lary muscles 9 (25.0%) pts. Residual MR ≤2+ was 14.7%
(5 pts) in group without MSA and nobody had in MSA
group (p = 0.023); residual SAM was 23.5% (8 pts) in
group without MSA and only 1 (2.7%) pts had in MSA
group (p = 0.01). Mean time cross clamping was 42.4 ±
15.2 min (without MSA) and 56.4 ± 20.8 min (MSA
group) (p = 0.002). Peak LVOT gradient was 12.2 ±
6.3 mm Hg (without MSA) and 8.7 ± 4.5 mm Hg (MSA
group) (p = 0.009).
Discussion/Conclusion
MSA intervention during septal myectomy in patients
with HOMC and MR safe and effective procedure.
Complex MSA intervention as in addition to septal
myectomy allows more effective eliminate SAM-
syndrome and MR.
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